US10188697 — Glycopeptide compositions
Method of Use · Assigned to Xellia Pharmaceuticals ApS · Expires 2035-11-06 · 9y remaining
What this patent protects
This patent protects methods of manufacturing and using stable solutions of glycopeptide antibiotics, such as Vancomycin, with added amino acids or derivatives.
USPTO Abstract
Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.
Drugs covered by this patent
- vancomycin-hydrochloride (VANCOMYCIN HYDROCHLORIDE)
- Vancocin (vancomycin) · ANI Pharmaceuticals
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-282 |
— | vancomycin-hydrochloride |
U-282 |
— | Vancocin |
U-282 |
— | vancomycin-hydrochloride |
U-282 |
— | vancomycin-hydrochloride |
U-282 |
— | vancomycin-hydrochloride |
U-282 |
— | vancomycin-hydrochloride |
U-282 |
— | vancomycin-hydrochloride |
U-282 |
— | vancomycin-hydrochloride |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.